The drug has not been granted approval by Australia's Therapeutic Goods Administration, or any other health authority in the world, for human use and is therefore banned by the World Anti-Doping Agency
This product is intended for research purposes only and is not approved for human use
Researchers have proposed that the peptide may influence dermal remodelling through regulation of collagen synthesis, extracellular matrix organisation and restoration of skin barrier function
Luteolin, a flavonoid containing four hydroxyl groups has anticancer properties mediated by oxidative stress suppression
The primary process involves H
Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al